141 related articles for article (PubMed ID: 11068328)
1. Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization.
Fu W; Bubendorf L; Willi N; Moch H; Mihatsch MJ; Sauter G; Gasser TC
Urology; 2000 Nov; 56(5):880-5. PubMed ID: 11068328
[TBL] [Abstract][Full Text] [Related]
2. Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization.
Wolter H; Gottfried HW; Mattfeldt T
BJU Int; 2002 Feb; 89(3):310-6. PubMed ID: 11856117
[TBL] [Abstract][Full Text] [Related]
3. Identification of genetic markers for prostatic cancer progression.
Alers JC; Rochat J; Krijtenburg PJ; Hop WC; Kranse R; Rosenberg C; Tanke HJ; Schröder FH; van Dekken H
Lab Invest; 2000 Jun; 80(6):931-42. PubMed ID: 10879743
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
5. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
Korn WM; Yasutake T; Kuo WL; Warren RS; Collins C; Tomita M; Gray J; Waldman FM
Genes Chromosomes Cancer; 1999 Jun; 25(2):82-90. PubMed ID: 10337990
[TBL] [Abstract][Full Text] [Related]
6. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
7. Genomic alterations associated with malignancy in head and neck cancer.
Bockmühl U; Wolf G; Schmidt S; Schwendel A; Jahnke V; Dietel M; Petersen I
Head Neck; 1998 Mar; 20(2):145-51. PubMed ID: 9484946
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.
Alers JC; Krijtenburg PJ; Vis AN; Hoedemaeker RF; Wildhagen MF; Hop WC; van Der Kwast TT; Schröder FH; Tanke HJ; van Dekken H
Am J Pathol; 2001 Feb; 158(2):399-406. PubMed ID: 11159178
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.
Cher ML; MacGrogan D; Bookstein R; Brown JA; Jenkins RB; Jensen RH
Genes Chromosomes Cancer; 1994 Nov; 11(3):153-62. PubMed ID: 7530484
[TBL] [Abstract][Full Text] [Related]
10. Genetic evaluation of localized prostate cancer in a cohort of forty patients: gain of distal 8q discriminates between progressors and nonprogressors.
van Dekken H; Alers JC; Damen IA; Vissers KJ; Krijtenburg PJ; Hoedemaeker RF; Wildhagen MF; Hop WC; van der Kwast TH; Tanke HJ; Schröder FH
Lab Invest; 2003 Jun; 83(6):789-96. PubMed ID: 12808114
[TBL] [Abstract][Full Text] [Related]
11. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
[TBL] [Abstract][Full Text] [Related]
14. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
Van Dekken H; Krijtenburg PJ; Alers JC
Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal basis of adenocarcinoma of the prostate.
Verma RS; Manikal M; Conte RA; Godec CJ
Cancer Invest; 1999; 17(6):441-7. PubMed ID: 10434955
[TBL] [Abstract][Full Text] [Related]
16. Genetic imbalances in pT2 breast cancers of southern Chinese women.
Fung LF; Wong N; Tang N; Lau A; Wong V; Pang CP; Suen M; King W; Johnson PJ
Cancer Genet Cytogenet; 2001 Jan; 124(1):56-61. PubMed ID: 11165323
[TBL] [Abstract][Full Text] [Related]
17. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer.
Chu LW; Troncoso P; Johnston DA; Liang JC
Genes Chromosomes Cancer; 2003 Mar; 36(3):303-12. PubMed ID: 12557230
[TBL] [Abstract][Full Text] [Related]
18. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of progression of prostate cancer.
Nupponen N; Visakorpi T
Eur Urol; 1999; 35(5-6):351-4. PubMed ID: 10325488
[TBL] [Abstract][Full Text] [Related]
20. Gain in chromosome 8q correlates with early progression in hormonal treated prostate cancer.
Steiner T; Junker K; Burkhardt F; Braunsdorf A; Janitzky V; Schubert J
Eur Urol; 2002 Feb; 41(2):167-71. PubMed ID: 12074404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
